USD 16.18
(-4.94%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 379.7 Million USD | -14.96% |
2022 | 450 Million USD | 23.52% |
2021 | 364.3 Million USD | -2.41% |
2020 | 373.3 Million USD | -7.19% |
2019 | 402.2 Million USD | 2.89% |
2018 | 390.9 Million USD | 16.03% |
2017 | 336.9 Million USD | -39.61% |
2016 | 557.9 Million USD | 4.95% |
2015 | 531.6 Million USD | -3.1% |
2014 | 548.6 Million USD | -10.39% |
2013 | 612.2 Million USD | 1.61% |
2012 | 602.5 Million USD | 1.98% |
2011 | 590.8 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 95.6 Million USD | 0.84% |
2024 Q3 | 92.9 Million USD | -2.82% |
2024 Q1 | 94.8 Million USD | -2.67% |
2023 Q3 | 95.5 Million USD | -2.35% |
2023 Q2 | 97.8 Million USD | -6.41% |
2023 Q1 | 104.5 Million USD | -10.61% |
2023 FY | 382.7 Million USD | -14.96% |
2023 Q4 | 97.4 Million USD | 1.99% |
2022 FY | 450 Million USD | 23.52% |
2022 Q4 | 116.9 Million USD | 6.18% |
2022 Q3 | 110.1 Million USD | -4.18% |
2022 Q2 | 114.9 Million USD | 7.18% |
2022 Q1 | 107.2 Million USD | 10.63% |
2021 Q2 | 85.7 Million USD | -6.13% |
2021 Q4 | 96.9 Million USD | 7.19% |
2021 FY | 364.3 Million USD | -2.41% |
2021 Q3 | 90.4 Million USD | 5.48% |
2021 Q1 | 91.3 Million USD | 2.7% |
2020 Q2 | 86.5 Million USD | -15.28% |
2020 Q1 | 102.1 Million USD | -6.93% |
2020 Q3 | 95.8 Million USD | 10.75% |
2020 FY | 373.3 Million USD | -7.19% |
2020 Q4 | 88.9 Million USD | -7.2% |
2019 Q4 | 109.7 Million USD | 15.47% |
2019 Q2 | 98.7 Million USD | -0.1% |
2019 Q3 | 95 Million USD | -3.75% |
2019 Q1 | 98.8 Million USD | -1.59% |
2019 FY | 402.2 Million USD | 2.89% |
2018 FY | 390.9 Million USD | 16.03% |
2018 Q4 | 100.4 Million USD | -4.11% |
2018 Q3 | 104.7 Million USD | 10.56% |
2018 Q2 | 94.7 Million USD | 3.95% |
2018 Q1 | 91.1 Million USD | 113.78% |
2017 Q3 | 143.3 Million USD | -0.9% |
2017 FY | 336.9 Million USD | -39.61% |
2017 Q4 | -661 Million USD | -561.27% |
2017 Q2 | 144.6 Million USD | 1.19% |
2017 Q1 | 142.9 Million USD | 0.14% |
2016 Q3 | 138 Million USD | -1.92% |
2016 FY | 557.9 Million USD | 4.95% |
2016 Q4 | 142.7 Million USD | 3.41% |
2016 Q2 | 140.7 Million USD | 3.08% |
2016 Q1 | 136.5 Million USD | 2.17% |
2015 FY | 531.6 Million USD | -3.1% |
2015 Q4 | 133.6 Million USD | 1.98% |
2015 Q3 | 131 Million USD | -2.89% |
2015 Q2 | 134.9 Million USD | 2.12% |
2015 Q1 | 132.1 Million USD | -15.59% |
2014 Q1 | 155 Million USD | -0.19% |
2014 FY | 548.6 Million USD | -10.39% |
2014 Q2 | 104.9 Million USD | -32.32% |
2014 Q4 | 156.5 Million USD | 18.38% |
2014 Q3 | 132.2 Million USD | 26.02% |
2013 Q2 | 154 Million USD | 8.91% |
2013 Q4 | 155.3 Million USD | -3.84% |
2013 Q1 | 141.4 Million USD | 0.0% |
2013 FY | 612.2 Million USD | 1.61% |
2013 Q3 | 161.5 Million USD | 4.87% |
2012 FY | 602.5 Million USD | 1.98% |
2011 FY | 590.8 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Abbott Laboratories | 22.13 Billion USD | 98.285% |
Allurion Technologies Inc. | 41.49 Million USD | -815.006% |
Artivion, Inc. | 229.17 Million USD | -65.681% |
Butterfly Network, Inc. | 16.85 Million USD | -2152.61% |
Butterfly Network, Inc. | 16.85 Million USD | -2152.61% |
Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 73.473% |
Boston Scientific Corporation | 9.89 Billion USD | 96.163% |
Perspective Therapeutics, Inc. | 1.63 Million USD | -23137.454% |
CONMED Corporation | 643.06 Million USD | 40.955% |
Edwards Lifesciences Corporation | 4.62 Billion USD | 91.79% |
Paragon 28, Inc. | 172.79 Million USD | -119.745% |
Glaukos Corporation | 239.13 Million USD | -58.78% |
Globus Medical, Inc. | 1.02 Billion USD | 62.786% |
Inspire Medical Systems, Inc. | 528.22 Million USD | 28.117% |
Integer Holdings Corporation | 418.28 Million USD | 9.225% |
Medtronic plc | 19.45 Billion USD | 98.048% |
Nevro Corp. | 290.06 Million USD | -30.904% |
Owlet, Inc. | 22.58 Million USD | -1581.055% |
Penumbra, Inc. | 682.64 Million USD | 44.378% |
Vicarious Surgical Inc. | -1.85 Million USD | 20580.043% |
Smith & Nephew plc | 3.7 Billion USD | 89.741% |
Sonendo, Inc. | 10.72 Million USD | -3441.317% |
STERIS plc | 2.23 Billion USD | 83.004% |
Stryker Corporation | 13.05 Billion USD | 97.092% |
Vapotherm, Inc. | 28.28 Million USD | -1242.503% |
Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 92.85% |